Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch

Giorgio Ciprandi; D. Fenoglio; M. De Amici; G. Marseglia; G. Murdaca; M. Di Gioacchino

Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch

Giorgio Ciprandi, D. Fenoglio, M. De Amici, G. Marseglia, G. Murdaca, M. Di Gioacchino

Research output: Contribution to journal › Article › peer-review

Abstract

Recently, it has been reported that IL-17 may be involved in allergic reaction. Sublingual immunotherapy (SLIT) is the unique curative treatment for allergic rhinitis. This study aims at investigating whether one course of birch SLIT could affect serum IL-17 levels. The findings provided show that some IL-17 producer patients had a reduction of serum IL-17 levels after one SLIT course. Therefore, this preliminary study shows that a single pre-seasonal SLIT course may induce a significant decreasing trend in serum IL-17 levels; further study should be carried out to define the role exerted by IL-17 in allergic rhinitis.

Original language	English
Pages (from-to)	49-51
Number of pages	3
Journal	European Journal of Inflammation
Volume	7
Issue number	1
Publication status	Published - Jan 2009

Keywords

Allergic rhinitis
IL-17
Sublingual immunotherapy

ASJC Scopus subject areas

Immunology
Immunology and Allergy

Cite this

@article{f706a220a7784b5aa0fa51a9f505d45e,

title = "Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch",

abstract = "Recently, it has been reported that IL-17 may be involved in allergic reaction. Sublingual immunotherapy (SLIT) is the unique curative treatment for allergic rhinitis. This study aims at investigating whether one course of birch SLIT could affect serum IL-17 levels. The findings provided show that some IL-17 producer patients had a reduction of serum IL-17 levels after one SLIT course. Therefore, this preliminary study shows that a single pre-seasonal SLIT course may induce a significant decreasing trend in serum IL-17 levels; further study should be carried out to define the role exerted by IL-17 in allergic rhinitis.",

keywords = "Allergic rhinitis, IL-17, Sublingual immunotherapy",

author = "Giorgio Ciprandi and D. Fenoglio and {De Amici}, M. and G. Marseglia and G. Murdaca and {Di Gioacchino}, M.",

year = "2009",

month = jan,

language = "English",

volume = "7",

pages = "49--51",

journal = "European Journal of Inflammation",

issn = "1721-727X",

publisher = "Biolife",

number = "1",

}

TY - JOUR

T1 - Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch

AU - Ciprandi, Giorgio

AU - Fenoglio, D.

AU - De Amici, M.

AU - Marseglia, G.

AU - Murdaca, G.

AU - Di Gioacchino, M.

PY - 2009/1

Y1 - 2009/1

N2 - Recently, it has been reported that IL-17 may be involved in allergic reaction. Sublingual immunotherapy (SLIT) is the unique curative treatment for allergic rhinitis. This study aims at investigating whether one course of birch SLIT could affect serum IL-17 levels. The findings provided show that some IL-17 producer patients had a reduction of serum IL-17 levels after one SLIT course. Therefore, this preliminary study shows that a single pre-seasonal SLIT course may induce a significant decreasing trend in serum IL-17 levels; further study should be carried out to define the role exerted by IL-17 in allergic rhinitis.

AB - Recently, it has been reported that IL-17 may be involved in allergic reaction. Sublingual immunotherapy (SLIT) is the unique curative treatment for allergic rhinitis. This study aims at investigating whether one course of birch SLIT could affect serum IL-17 levels. The findings provided show that some IL-17 producer patients had a reduction of serum IL-17 levels after one SLIT course. Therefore, this preliminary study shows that a single pre-seasonal SLIT course may induce a significant decreasing trend in serum IL-17 levels; further study should be carried out to define the role exerted by IL-17 in allergic rhinitis.

KW - Allergic rhinitis

KW - IL-17

KW - Sublingual immunotherapy

UR - http://www.scopus.com/inward/record.url?scp=65549151846&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549151846&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:65549151846

VL - 7

SP - 49

EP - 51

JO - European Journal of Inflammation

JF - European Journal of Inflammation

SN - 1721-727X

IS - 1

ER -

Serum IL-17 after one course of sublingual immunotherapy in allergic rhinitis to birch

Abstract

Keywords

ASJC Scopus subject areas

Other files and links

Fingerprint

Cite this